Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
For Arterburn, this has meant not only leading research to answer pressing questions about GLP-1s, but also devising best practices for studying these medications and supporting patients and clinicians during what The New York Times has called the great American GLP-1 experiment. Arterburns prior focus as an obesity researcher was on weight-loss (bariatric) surgery
PPIs offer potent acid suppression for moderate to severe symptoms
2001, 4 (6A): 1325-1329
The move could significantly expand access to these treatments for people with diabetes and obesity
US$ 26.60
US$ 26.01
US$ 28.88
